Rising Pneumococcal Antibiotic Resistance in the Post 13-valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates from a Primary Care Setting

  19 February 2020

Antibiotic-resistant S. pneumoniae strains may cause infections that fail to respond to antimicrobial-therapy. Results reported from hospitalized patients with invasive, bacteremic infections may not be the same as those observed in a primary-care setting where young children receive care for non-invasive infections. Young children experience the highest burden of pneumococcal disease.

Author(s): Ravinder Kaur, Minh Pham, Karl O A Yu, Michael E Pichichero
Healthy Animals  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!